Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Myopericarditis in a Korean Young Male With Systemic Lupus Erythematosus

  • Park, Kyu-Tae (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Hong, Kyung-Soon (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Han, Sang-Jin (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Yoon, Duck-Hyoung (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Choi, Hyun-Hee (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Lee, Min-Young (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Ryu, Myeong-Shin (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Lee, Chan-Woo (Department of Internal Medicine, Hallym University College of Medicine)
  • Published : 2011.06.30
⟨ Previous Next ⟩

Abstract

Myocardial involvement with clinical symptoms is a rare manifestation of systemic lupus erythematosus (SLE), despite the relatively high prevalence of myocarditis at autopsies of SLE patients. In this review, we report the case of a 19-year-old male SLE patient who initially presented with myopericarditis and was successfully treated with high dose of glucocorticoids.

Keywords

References

  1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum 1982;25:1271-7. https://doi.org/10.1002/art.1780251101
  2. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Preval-ence of adult systemic lupus erythematosus in California and Pennsyl-vania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 2007;56:2092-4. https://doi.org/10.1002/art.22641
  3. Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999;11:352-6. https://doi.org/10.1097/00002281-199909000-00005
  4. Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med 2002;113:419-23. https://doi.org/10.1016/S0002-9343(02)01223-8
  5. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Car-diac involvement in systemic lupus erythematosus. Lupus 2005;14: 683-6. https://doi.org/10.1191/0961203305lu2200oa
  6. Bidani AK, Roberts JL, Schwartz MM, Lewis EJ. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 1980;69:849-58. https://doi.org/10.1016/S0002-9343(80)80010-6
  7. Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987;17:126-41. https://doi.org/10.1016/0049-0172(87)90035-7
  8. Moder KG, Miller TD, Tazellar HD. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 1999;74:275-84. https://doi.org/10.4065/74.3.275
  9. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343: 1388-98. https://doi.org/10.1056/NEJM200011093431908
  10. Murphy JG, Franz RP. Endomyocardial biopsy in myocarditis. In: Cooper LT, editor. Myocarditis: From Bench to Bedside. Totowa, NJ: Humana, Press; 2003; p.371-89.
  11. Noutsias M, Pauschinger M, Poller WC, Schultheiss HP, Kühl U. Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy. Heart Fail Monit 2003;3:127-35.
  12. Park JI, Jeon ES. Mechanical circulatory supports in the treatment of fulminent myocarditis. Korean Circ J 2005;35:563-72.

Cited by

  1. Management of myopericarditis vol.11, pp.2, 2013, https://doi.org/10.1586/erc.12.184